Cybin (HELP) Non Operating Income (2020 - 2025)
Cybin (HELP) reported Non Operating Income of $7.94 for Q2 2025, down 99.73% on a YoY basis from $2935.5 in Q2 2024, and down 99.95% quarter-over-quarter from $14862.5 in Q4 2024.
Cybin (HELP) Non Operating Income (2020 - 2025) Analysis & Trends
Cybin has reported Non Operating Income for 6 years, with the latest figure at $7.94 in Q2 2025.
- For the quarter ending Q2 2025, Non Operating Income fell 99.73% year-over-year to $7.94; the trailing twelve-month figure through Jun 2025 stood at $796308.6 (up 391.36% YoY), and the FY2023 full-year result was $16003.3, changed N/A from the prior year.
- Non Operating Income for Q2 2025 stood at $7.94, down from $14862.5 in the prior quarter.
- The five-year high for Non Operating Income was $1.8 million in Q3 2022, with the low at -$1.3 million in Q2 2023.
- Historically, Non Operating Income has averaged $280754.1 across 5 years, with a median of $2935.5 in 2024.
- Annual changes were most pronounced in 2021 — Non Operating Income sank 1852.17% — and 2024, when it jumped 712.03%.
- Cybin's Non Operating Income stood at -$598968.7 in 2021, then soared by 266.17% to $995285.7 in 2022, then tumbled by 100.24% to -$2428.4 in 2023, then jumped by 712.03% to $14862.5 in 2024, then slumped by 99.95% to $7.94 in 2025.
- The last three Non Operating Income figures came in at $7.94 (Q2 2025), $14862.5 (Q4 2024), and $778502.7 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | 7.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 7.94 |
| Dec 31, 2024 | 14,862.46 |
| Sep 30, 2024 | 778,502.72 |
| Jun 30, 2024 | 2,935.53 |
| Dec 31, 2023 | -2,428.37 |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | -1.35 Mn |
| Feb 28, 2023 | 1.52 Mn |
| Dec 31, 2022 | 995,285.67 |
| Sep 30, 2022 | 1.80 Mn |
| Dec 31, 2021 | -598,968.74 |
| Sep 30, 2021 | -397,999.06 |
| Jun 30, 2021 | -632,924.13 |
| Dec 31, 2020 | -30,682.19 |
| Sep 30, 2020 | -74,291.94 |
| Jun 30, 2020 | -103,132.16 |